Company news

YungShin Global Holding Corp. news

Latest news releases, newest first.

View company

YungShin Global Announce the Company's Board of Directors approved the consolidated financial statements for the period ended June 30, 2022.

August 10, 2022

Announcement of the Company's Board of Directors resolved the removal of the non-compete clause for Vice President

August 10, 2022

Announcement of Company's Board of Directors appointment of Vice President

August 10, 2022

Announcement of company leases and acquire the right-of-use assets from related party

August 10, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co., Ltd. the changes of spokesperson and acting spokesperson

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co., Ltd. the Board meeting on removal of the non-compete clause for President

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd.,the Board resolutions on record date for capital increase issuance of new shares

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd.,the Board resolutions on election of Chairman, Vice Chairman cum President

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd.,Board acting shareholders' meeting for removal of non-compete clause for Directors

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd.,the important resolutions of the board meeting

August 9, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co., Ltd. the Board resolution on donation to related parties

August 9, 2022

Announcement on behalf subsidiary, YSP Inc. Co. Ltd., on disposal of shares equity of Yung Shin China Holding Co. Ltd.(complementary announcement-2021/12/29)

August 1, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd.,the Company's 3rd Audit Committee members

July 29, 2022

Re-issue announcement on behalf of subsidiary, Vetnostrum Animal Health Co. Ltd.,Acquire right-of-use assets from related parties

July 29, 2022

Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co. Ltd., the reassignment upon term expired for Directors (including independent Directors)

July 29, 2022

Announcement on behalf of major subsidiary, Vetnostrum Animal Health Co. Ltd., the important resolutions of the Board acting shareholders'meeting

July 29, 2022

Announcement on behalf of major subsidiary, Vetnostrum Animal Health Co., Ltd. the Board of Directors on election of Chairman and President

July 29, 2022

Announcement on behalf of major subsidiary, Vetnostrum Animal Health Co., Ltd. the Board meeting on lifting of the non-compete clause for President

July 29, 2022

Announcement on behalf major subsidiary,Vetnostrum Animal Health Co. Ltd., Board acting shareholders' meeting for lifting the non-compete clause for Director

July 29, 2022

Announcement on behalf of subsidiary, Vetnostrum Animal Health Co., Ltd. change in representative of the Co's Institutional Director and Supervisor.

July 25, 2022

Announcement on behalf of subsidiary, Carlsbad Technology, Inc. the Board of Directors on election of Chairman

July 22, 2022

Announcement on behalf of subsidiary, Carlsbad Technology, Inc. the important resolutions of the shareholders' meeting

July 21, 2022

Announcement on behalf of subsidiary, Carlsbad Technology, Inc. change in representative of the Company's Institutional Director.

July 21, 2022

Announcement decrease in the number of held companies in the Company's portfolio

June 30, 2022